Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications

被引:2
|
作者
Carlino, Francesca [1 ]
Solinas, Cinzia [2 ]
Orditura, Michele [3 ]
Bisceglia, Maria Dezia [4 ]
Pellegrino, Benedetta [5 ]
Diana, Anna [6 ]
机构
[1] Osped Ave Gratia Plena, Med Oncol Unit, San Felice A Cancello, Caserta, Italy
[2] Azienda Osped Univ AOU Cagliari Policlin Duilio Ca, Azienda Osped Univ AOU Cagliari Policlin Duilio Ca, Cagliari, Italy
[3] Med Oncol Unit, Aienda Osped Rilievo Nazl AORN St Anna & San Sebas, Caserta, Italy
[4] Aienda Osped Rilievo Nazl AORN St Anna & San Sebas, Aienda Ospedaliera Rilievo Nazl A O R N St Anna &, Caserta, Italy
[5] Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy
[6] Osped Mare, Med Oncol Unit, Naples, Italy
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
breast cancer; heterogeneity; molecular mechanisms; drug resistance; emerging technologies;
D O I
10.3389/fonc.2024.1321654
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
    Brooks, Michael D.
    Burness, Monika L.
    Wicha, Max S.
    CELL STEM CELL, 2015, 17 (03) : 260 - 271
  • [2] Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications
    Pareja F.
    Marchiò C.
    Geyer F.C.
    Weigelt B.
    Reis-Filho J.S.
    Current Breast Cancer Reports, 2017, 9 (1) : 34 - 44
  • [3] A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies
    Li, Xin
    Thirumalai, D.
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2022, 19 (186)
  • [4] Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
    Zeng, Xiaobin
    Liu, Chengxiao
    Yao, Jie
    Wan, Haoqiang
    Wan, Guoqing
    Li, Yingpeng
    Chen, Nianhong
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [5] Clinical and Therapeutic Implications of Histone Acetylation in Breast Cancer
    Riaz, S. K.
    Saeed, M.
    Malik, M. F. A.
    WEST INDIAN MEDICAL JOURNAL, 2016, 65 (02): : 337 - 344
  • [6] Breast cancer complexity: implications of intratumoral heterogeneity in clinical management
    Brittany Haynes
    Ashapurna Sarma
    Pratima Nangia-Makker
    Malathy P. Shekhar
    Cancer and Metastasis Reviews, 2017, 36 : 547 - 555
  • [7] Genomic heterogeneity in primary breast cancer: Clinical implications.
    Connolly, Lucy Rebecca
    Knappskog, Stian
    Desmedt, Christine
    Wedge, David
    Van Loo, Peter
    Gerstung, Moritz
    Fatima, Aquila
    Richardson, Andrea
    Lonning, Per Eystein
    Sotiriou, Christos
    Stratton, Michael R.
    Campbell, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Biological heterogeneity of micrometastatic breast cancer cells: Clinical implications
    Pantel, K
    Braun, S
    Schlimok, G
    Riethmuller, G
    BLOOD, 1996, 88 (10) : 1921 - 1921
  • [9] Breast cancer complexity: implications of intratumoral heterogeneity in clinical management
    Haynes, Brittany
    Sarma, Ashapurna
    Nangia-Makker, Pratima
    Shekhar, Malathy P.
    CANCER AND METASTASIS REVIEWS, 2017, 36 (03) : 547 - 555
  • [10] Breast cancer intratumour heterogeneity: current status and clinical implications
    Joseph, Chitra
    Papadaki, Athanasia
    Althobiti, Maryam
    Alsaleem, Mansour
    Aleskandarany, Mohammed A.
    Rakha, Emad A.
    HISTOPATHOLOGY, 2018, 73 (05) : 717 - 731